# Von Willebrand Factor Concentrate During ECMO Support

> **NCT03613584** · PHASE2 · UNKNOWN · sponsor: **Tirol Kiniken GmbH** · enrollment: 68 (estimated)

## Conditions studied

- Acquired Von Willebrand Disease

## Interventions

- **DRUG:** Von Willebrand Factor
- **DRUG:** Saline Solution

## Key facts

- **NCT ID:** NCT03613584
- **Lead sponsor:** Tirol Kiniken GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-16
- **Primary completion:** 2021-03-10
- **Final completion:** 2021-03-10
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2020-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03613584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03613584, "Von Willebrand Factor Concentrate During ECMO Support". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03613584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*